Thermo Fisher – 2023 new APS classification criteria
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
We are pleased to launch the 2024 edition of the Thermo Fisher Phadia product catalogue for ImmunoCAP and EliA.
Phadia 2500+, capacity and productivity that meet the growing demands for laboratories to aid in diagnosing allergic and autoimmune diseases.
Products are for Professional/Laboratory use only
We would like to share with you an overview from Thermo Fisher on the Coefficient of Variation (CV) in the EliA™ well DFUs.
Products are for professional/laboratory use only.
Explore the new range of Theradiag IMMUNO-TROL FEIA – a complete range of third-party Quality Controls specifically designed for use with Phadia EliA assays. IMMUNO-TROL FEIA is suitable for use on the Thermo Fisher Phadia range of systems – Phadia 250, Phadia 2500E/EE, Phadia 200.
Products are for professional/laboratory use only.
Antiphospholipid syndrome (APS) is an autoimmune disease which is characterized by the formation of various antibodies against phospholipids and a blood hypercoagulability.
Products are for professional/laboratory use only. ImmunoCAP component from Thermo Fisher – Allergen Component rSes i 1 Sesame seed.
If you are looking to detect low-abundant proteins at the femtogram/mL level with the sensitivity and speed? The SMCxPRO™ immunoassay system is ideal to move your research to new levels.
With a comprehensive list of Merck MILLIPLEX, Single Molecule Counting (SMC) and ELISA immunoassays, including new Multiplex kits for COVID-19 research, human, high sensitivity and animal species panels.